Scarica l'app Stockscreener
26.70
2.50%
0.655
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché PHG Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$26.05
Aprire:
$26.44
Volume 24 ore:
1.21M
Relative Volume:
1.13
Capitalizzazione di mercato:
$25.42B
Reddito:
$20.45B
Utile/perdita netta:
$1.12B
Rapporto P/E:
22.91
EPS:
1.1658
Flusso di cassa netto:
$1.75B
1 W Prestazione:
+4.18%
1M Prestazione:
-8.53%
6M Prestazione:
-0.03%
1 anno Prestazione:
+11.44%
Intervallo 1D:
$26.20
$26.82
Intervallo di 1 settimana:
$25.19
$26.82
Portata 52W:
$21.95
$33.44
Koninklijke Philips Nv Adr Stock (PHG) Company Profile
Nome
Koninklijke Philips Nv Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare PHG vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PHG
Koninklijke Philips Nv Adr
|
26.70 | 24.80B | 20.45B | 1.12B | 1.75B | 1.1658 |
ABT
Abbott Laboratories
|
88.50 | 153.12B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
322.49 | 120.08B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.04 | 99.27B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
56.48 | 83.12B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.44 | 47.44B | 6.30B | 1.07B | 1.09B | 1.8406 |
Koninklijke Philips Nv Adr Stock (PHG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-17 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2025-02-25 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2025-02-20 | Aggiornamento | UBS | Neutral → Buy |
| 2024-10-29 | Aggiornamento | Jefferies | Underperform → Hold |
| 2024-05-13 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-05-07 | Aggiornamento | Exane BNP Paribas | Underperform → Neutral |
| 2024-04-30 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-04-30 | Aggiornamento | UBS | Sell → Neutral |
| 2024-02-07 | Downgrade | Exane BNP Paribas | Outperform → Underperform |
| 2023-07-12 | Iniziato | Goldman | Buy |
| 2023-01-17 | Downgrade | UBS | Neutral → Sell |
| 2022-10-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-10-14 | Downgrade | Deutsche Bank | Hold → Sell |
| 2022-09-12 | Aggiornamento | Societe Generale | Hold → Buy |
| 2022-09-06 | Aggiornamento | UBS | Sell → Neutral |
| 2022-07-25 | Downgrade | Societe Generale | Buy → Hold |
| 2022-06-16 | Downgrade | UBS | Neutral → Sell |
| 2022-01-20 | Downgrade | Jefferies | Buy → Hold |
| 2022-01-14 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2022-01-12 | Downgrade | Citigroup | Buy → Neutral |
| 2021-09-08 | Iniziato | Jefferies | Buy |
| 2021-07-08 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-06-21 | Downgrade | HSBC Securities | Buy → Hold |
| 2021-03-18 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-07-28 | Iniziato | Societe Generale | Buy |
| 2019-07-30 | Iniziato | Citigroup | Buy |
| 2018-02-12 | Aggiornamento | Berenberg | Hold → Buy |
| 2017-11-09 | Downgrade | JP Morgan | Overweight → Neutral |
| 2017-10-16 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2017-06-21 | Downgrade | Natixis Bleichroeder | Buy → Neutral |
| 2017-04-25 | Downgrade | Societe Generale | Buy → Hold |
| 2016-12-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-23 | Iniziato | Citigroup | Buy |
| 2016-05-11 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2016-03-01 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2016-02-16 | Downgrade | Jefferies | Hold → Underperform |
| 2015-11-27 | Iniziato | ING Group | Hold |
| 2015-09-08 | Iniziato | Credit Suisse | Outperform |
| 2015-08-27 | Aggiornamento | Nomura | Neutral → Buy |
| 2015-07-28 | Aggiornamento | Societe Generale | Hold → Buy |
| 2011-01-25 | Downgrade | HSBC Securities | Overweight → Neutral |
| 2009-12-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2009-10-16 | Aggiornamento | HSBC Securities | Neutral → Overweight |
| 2009-05-08 | Downgrade | UBS | Buy → Neutral |
Mostra tutto
Koninklijke Philips Nv Adr Borsa (PHG) Ultime notizie
symbol__ Stock Quote Price and Forecast - CNN
Philips introduces SmartIQ to address the trade-off between image quality and radiation dose in coronary procedures - Sahm
Nebulizers - GlobeNewswire Inc.
Koninklijke Philips N.V. stock (NL0000009538): new SmartIQ imaging launch keeps focus on health-tech - AD HOC NEWS
Philips highlights advances in imaging and physiology to support complex PCI at EuroPCR 2026 - GlobeNewswire Inc.
Philips to deliver vital technology for hospital-at-home care for up to 15,000 patients annually in Region Stockholm - Finviz
PHGKoninklijke Philips NV ADR Stock Price and Quote - Finviz
Koninklijke Philips N.V. ADR Unsponsored Brazilian Depository Receipt Repr 1 ADR - TradingView
QuickLogic Posts Downbeat Q1 Results, Joins Resideo Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Sahm
Koninklijke Philips N.V. stock (NL0000009538): ex-dividend date set for May 12 - AD HOC NEWS
Koninklijke Philips N.V. Stock (NL0000009538): Analyst Rating Change and Price Move on May 7, 2026 - AD HOC NEWS
Philips shareholders approve all proposals at the AGM 2026 - Finviz
Earnings call transcript: Philips Q1 2026 sees solid revenue but EPS miss - Investing.com
Earnings call transcript: Koninklijke Philips misses Q1 2026 EPS forecast By Investing.com - Investing.com Canada
Earnings call transcript: Koninklijke Philips misses Q1 2026 EPS forecast - Investing.com
Philips Reports Strong Order Intake Despite Uncertain Macro Environment - Sahm
Sleep Apnea Devices (Therapeutic, Diagnostic) Market Report 2026-2034 Featuring Key Players - GlobeNewswire Inc.
Sony Group Corp. ADR outperforms competitors despite losses on the day - MarketWatch
Sony Group Corp. ADR falls Thursday, underperforms market - MarketWatch
Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction - Sahm
Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning - Finviz
Sony Group Corp. ADR falls Monday, underperforms market - MarketWatch
Koninklijke Philips (ADR) stock (NL0000009538): Why Google Discover changes matter more now - AD HOC NEWS
Philips receives FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications - Sahm
Sony Group Corp. ADR rises Friday, still underperforms market - MarketWatch
Philips receives FDA 510(k) clearance for Verida, the world's first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications - Finviz
Sony Group Corp. ADR rises Wednesday, still underperforms market - MarketWatch
Koninklijke Philips (ADR) stock (NL0000009538): Why its focus on diagnostics and AI tools matters mo - AD HOC NEWS
Koninklijke Philips (ADR) stock (NL0000009538): Why its focus on healthcare innovation matters more - AD HOC NEWS
Koninklijke Philips N.V. (PHG) Stock Price, News, Quote & History - Yahoo! Finance Canada
MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member - Sahm
Sony Group Corp. ADR rises Wednesday, outperforms market - MarketWatch
FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair - Finviz
Philips launches IntraSight Plus to simplify coronary interventions and advance precision care - Finviz
Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant - Sahm
Philips convenes the Annual General Meeting of Shareholders 2026 - Finviz
Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment - Finviz
Sony Group Corp. ADR falls Wednesday, underperforms market - MarketWatch
Koninklijke Philips N.V. Stock (ISIN: NL0000009538) Holds Steady Amid Neutral Analyst Views and AI-D - AD HOC NEWS
Koninklijke Philips (ADR) Stock Gains Traction as Earnings Beat Expectations Amid Health Tech Recove - AD HOC NEWS
PHIA Stock Price and Chart — EURONEXT:PHIA - TradingView
Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite - Finviz
Philips connects patient monitoring and diagnostics to advance platform-based care intelligence at HIMSS26 - Finviz
NVIDIA Upgraded, Eli Lilly Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Philips Sonicare unveils two new electric toothbrush ranges alongside refreshed brand direction - Finviz
Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments - Finviz
SHERPA research consortium initiates seven clinical studies to validate AI-based assistive technologies for minimally invasive brain and cancer treatments - Finviz
Koninklijke Philips Nv Adr Azioni (PHG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.13%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):